肝脾联合切除治疗肝癌伴肝硬化脾功能亢进临床研究

The Clinical Research of Liver Cancer Accompanied Cirrhosis of Liver Cirrhosis Treated by United Liver and Spleen Resection

目的：研究肝脾联合切除治疗肝癌伴肝硬化脾功能亢进的临床效果。方法选取2008年9月-2015年9月在我院进行治疗的肝癌伴肝硬化脾功能亢进患者94例，按手术方式不同分为两组，各47例。对照组实施单纯肝切除术，研究组进行肝脾联合切除术治疗，对两组患者血常规检测白细胞计数（WBC）、血小板计数（PLT）及并发症发生情况进行比较。结果治疗后研究组WBC及PLT指标较对照组提高，差异具有统计学意义（P＜0.05）；术后两组患者并发症发生率，差异无统计学意义（P＞0.05）。结论对肝癌伴肝硬化脾功能亢进患者实施肝脾联合切除，有助于提高治疗效果，且安全性较高。

Objective To study the clinical effect of liver cancer accompanied cirrhosis of liver cirrhosis treated by united liver and spleen resection. Methods We selected the 94 cases of patients with the cirrhosis of liver cirrhosis at our hospital from the September 2014 to September 2015,to divided into two groups as the different operation methods,each 47 cases. The control group was implemented by pure hepatectomy,and the treatment group was implemented by the united liver and spleen resection. To compared the white blood cell count （WBC）by brood routine test of patients,blood platelet count（PLT）and occurrence of complications of them. ResultsAfter treatment, the index of WBC and PLT of the treatment group was significantly improved that compared with the control group,there was statistical significance（P〈0.05）. To compared the incidence of complications of them after treatment,there was no statistical significance（P〉0.05）. Conclusion That help to improving the treatment effect of liver cancer accompanied cirrhosis of liver cirrhosis treated by united liver and spleen resection,and with higher safety.